Answered step by step
Verified Expert Solution
Question
1 Approved Answer
Comparable Transaction Analysis Exercise Company Share price Shares outstanding Revenue EBITDA Target Roche Wyeth Net income Net debt Comparable transactions Schering-Plough Genzyme Eli Lilly
Comparable Transaction Analysis Exercise Company Share price Shares outstanding Revenue EBITDA Target Roche Wyeth Net income Net debt Comparable transactions Schering-Plough Genzyme Eli Lilly $50.00 Mean 1b $20b $6.5b $5b $1b Acquirer Genentech Pfizer Merck Sanofi Implied Eli share price Is Eli overvalued based on comps? Offer value [Sb) $47 $68 $41 $20 Premium Paid 19.0% 18.0% 23.0% 23.0% 20.8% TV / Revenue 2.00 3.00 1.50 2.50 2.25 Lilly TV / EBITDA 8.00 12.00 11.00 13.00 11.00 Offer price /EPS 16.00 20.00 16.00 18.00 17.50
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Okay lets analyze this and determine if Eli Lilly is overvalued based on com...
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started
Financial Reporting Financial Statement Analysis And Valuation A Strategic Perspective
Authors: James M. Wahlen, Stephen P. Baginski, Mark Bradshaw
8th Edition
1285190904, 978-1305176348, 1305176340, 978-1285190907
